Additional information
Light Yellow Powder
98814-60-9
ACI-036102
NA
C21H23N7O8
501.45
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
(2S)-2-[[4-[[[(6RS)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl] formylamino]benzoyl]amino]pentanedioic acid
(2S)-2-[[4-[[[(6RS)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl]formylamino]benzoyl]amino]pentanedioic acid (5,10-diformyltetrahydrofolic acid)
5,10-diformyltetrahydrofolic acid





![BOSUTINIB CHLOROMETHYL QUATERNARY CHLORIDE SALT (25 mg) (1-(Chloromethyl)-4-{3-[(3-cyano-4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxyquinolin-7-yl)oxy]propyl}-1-methylpiperazin-1-ium Chloride )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)